The U.S. Food and Drug Administration (FDA) has approved the skin-care medicine Botox for use in people with chronic migraines. Injections of Botox would be given to patients in the head and neck area every 12 weeks in an effort to prevent future migraines. Experts say that Botox has not been shown to be effective for people who experience fewer than 14 headache days per month.
The FDA has now approved Botox (onabotulinumtoxinA) for the treatment of chronic Migraine. Russell Katz, M.D., director of the Division of... Read more »
Migraine prevention is a major concern for many of us, and we're always looking for more options. One option that more and more... Read more »
Since so many people have been interested in Botox for Migraine and headache prevention, I wanted to post a quick note today. Yesterday,... Read more »
Many Migraine patients, especially who find oral medications don't work well for them and / or have problems with nasal sprays and... Read more »
The FDA announced yesterday the approval of the first generic versions of Depakote delayed-release (divalproex sodium). Depakote is FDA... Read more »
The FDA has now approved Botox (onabotulinumtoxinA) for the treatment of chronic Migraine. Russell Katz, M.D., director of the Division of... Read more »
The U.S. Food and Drug Administration (FDA) has decided to delay its approval of the wrinkle med Botox for the treatment of upper limb muscle... Read more »
The U.S. Food and Drug Administration (FDA) has approved the drug Dysport as a new wrinkle treatment. Dysport is very similar to Botox, since it... Read more »
Migraine prevention is one of the most important issues facing Migraineurs who experience frequent and / or debilitating Migraine attacks. The vast... Read more »
There's good news about abortive treatment of Migraine with aura - without medications. A portable Transcranial Magnetic Stimulation (TMS) device... Read more »